ATH alterity therapeutics limited

News drop

  1. 4,185 Posts.
    lightbulb Created with Sketch. 425
    Hmmm, so we continue to wait for the next news drop. Dr Stamler advised we should have final read of at least 202 study by end of July from the Update presentation, and we are now at the end of August, and now bouncing between 0.013-0.012c.

    No doubt alot of talks and mechanisms taking place behind the scenes, which include:

    -Completion of PMI drug manufactoring requirements for upcoming ph 3;
    -Compiling peer review material for upcoming presentations;
    - upcoming FDA meetings;
    - indepth discussions with potential partners;
    - FDA submissions and upcoming/current talks;
    - results to return from Europe to provide correct biomarker results (hopefully significantly better than first released);
    - setting up ph 3, discussing and opening up potential further study sites around the globe.

    Is there anything thats going to cause this company to collapse, I see nothing. With the small workforce, they would all be under alot of strain to ensure things are in order for the next steps.

    I'll be surprised if we dont see anything sometime this week or definately next, especially when the next presentation which is to include the peer review and final results from 202/201 studies to be presented is only 4-5wks away....patience everyone.
    Last edited by Scottsmyname: 25/08/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.3¢
Change
0.001(4.17%)
Mkt cap ! $115.1M
Open High Low Value Volume
1.2¢ 1.3¢ 1.2¢ $23.62K 1.963M

Buyers (Bids)

No. Vol. Price($)
36 13709491 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 9965135 14
View Market Depth
Last trade - 15.59pm 12/09/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.